Q: I have these excellent performing stocks in my portfolio and wish to add to one of them. Percentages are as follows:
BAM.A - 3.8%
BYD.UN - 4.96%
WSP - 4.35%
Which one would you add to for growth and reliability over say 2- 5yrs, if you ignore the lower BAM % and then if you consider it has been brought up to the level of the other two?
Q: Great market response to decent Q($13.60 up .85).How was conference call? Time to add to my 3.5% position($17.28 p/p) Thanks for u usual great services & views
Q: I was expecting Armageddon/ volatility in the markets with no China deal and more tariffs and China retaliation. What gives? At some point this is going to impact earnings, jobs, etc. In fact the market has risen, what do you make of it?
Many things seem to be working against Micron. Would you advise selling now until Trump and his games play out or do you think most of that uncertainty is accounted for. Down about 10%
Q: Mosaic has reported improved revenue, EBITDA, FCF and Payout Ratio vs Y2018, and the share price has responded positively. Looking past EBITDA, however, I see that income has not just declined but reversed; what is it about the former metrics that leads the market to ignore the latter? Is the idea, here, that income will go up and down as the company makes investments , but as long as the company is growing then per-year income doesn't matter so much?
Q: Hi,
Can you tell me why the stock had a big drop within the last few days? And what is your sentiment about adding this stock to my non-registered investment portfolio (2-3%) - i had a big gain with mastercard since 2010 and wanted to diversify with coke company. Thanks!
Q: I like to look at debt to EBITDA as a key indicator of financial risk in a stock. Can you provide information on a good source for this ratio for Canadian and US stocks?
Q: I've owned a 1000 SHS since last Jan. and I am down 42% or so: missed last Q badly, increased dividend nicely, low pay-out ratio. Hold in my non-registered account - fairly small holding vs total portfolio. I was thinking of adding another 1000 SHS. In hind sight I should have sold in Dec. 2018 to record a tax loss and bought back later. I'd like to see less debt.; but, realize very capital intensive industry - ROE 18% ROI not that impressive though. Good idea for long-term arisen to add now?
Q: I own all of these in equal weighting (7% each). Down quite a bit on NFI. Just seeing if I should keep it and give it the long term (10 years) to provide a good return or sell because there is a better company to replace it with for a better long term performance at this point. Any other recommendations as I do have some cash side lined at this point (30%).
Q: Good morning,
Thank you for your response and suggestion that I get my broker to move shares, such as AQN and BAM, that pay dividends in US$ to my US$ Non Registered account in order to save on f/x conversion fees.
This is a follow up to your response and your thoughts and appropriateness of the following strategy to save on f/x conversion fees.
Objective. To increase the Tech/Med sector exposure in my US$ Non Reg account, I would like to purchase a few ETFs that are denominated in US$.
Question. To save on f/x conversion fees, could I simply purchase a stock such as AQN or BAM in my Cdn$ Non Reg Account and then have my broker transfer the stock (s) to my US$ Non Reg account where I would then sell them and purchase my US$ denominated Med/Tech ETFs. Would this be an efficient way of accomplishing my stated objective?
I thank you in advance and look forward to hearing your thoughts and response to this potential f/x conversion fee saving strategy.
Q: We need to bump our US tech exposure and would like to know your opinion on IBM. We are also interested in Microsoft ( which you like) but the dividend payout on IBM looks more inviting. Thanks